Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites.
Katerina A ChristopoulosJonathan ColasantiMallory O JohnsonManami Diaz TsuzukiXavier A ErgueraRey FloresJared KermanKaylin DanceJohn A SaucedaTorsten B NeilandsSamantha E DilworthKimberly A KoesterJose GutierrezJohn A SchneiderElizabeth MontgomeryMoira C McNultyPublished in: Open forum infectious diseases (2022)
Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- primary care
- end stage renal disease
- healthcare
- case report
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- quality improvement
- peritoneal dialysis
- palliative care
- men who have sex with men
- pain management
- chronic pain
- south africa
- patient reported